Inhibition of 6-Phosphogluconate Dehydrogenase Reverses Epirubicin Resistance Through Metabolic Reprograming in Triple-Negative Breast Cancer Cells.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT（2023）
Key words
6PGD,chemotherapy resistance,epirubicin,metabolic reprograming,triple-negative breast cancer (TNBC)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined